Fisiologia e nosografia degli antiaggreganti

Translated title of the contribution: Physiology and nosography of antiplatelet drug

D. Mari

Research output: Contribution to journalArticlepeer-review


The place of antiplatelet drugs in clinical medicine has been firmly established by experience with aspirin. Antiplatelet Trialists' Collaboration demonstrated that some antiplatelet therapy offers worthwile protection against myocardial infarction, stroke and death. Significant benefit is evident also among many other categories of high risk patients (such as those having vascular procedures and those with unstable angina or peripheral vascular disease). More potent platelet inhibitors have been developed and the challenge of the coming years is if they can be used practically and safety at effective doses in humans. Large scale randomized trials are now ongoing to provide reliable data on secondary prevention of vascular and cerebrovascular events of new interesting drugs.

Translated title of the contributionPhysiology and nosography of antiplatelet drug
Original languageItalian
Pages (from-to)541-545
Number of pages5
JournalGiornale di Gerontologia
Issue number10
Publication statusPublished - 1995

ASJC Scopus subject areas

  • Ageing
  • Geriatrics and Gerontology


Dive into the research topics of 'Physiology and nosography of antiplatelet drug'. Together they form a unique fingerprint.

Cite this